Glioma cell invasion is promoted via the overexpression of receptors such as MET or EGFR, as well as downstream signaling through PI3K and MAPK pathways, and the Rho family of GTPases, among others (8, 9). This evidence concerns the gene RHO and central nervous system cancer.